Intra-articular Corticosteroid Injection of the Right Glenohumeral Joint: Technique
For glenohumeral joint injection, use the anterior rotator interval approach with ultrasound guidance, injecting 20-40 mg triamcinolone with local anesthetic into the glenohumeral joint space. 1, 2
Pre-Procedure Requirements
Patient Preparation
- Obtain informed consent documenting the procedure nature, potential benefits, risks, and post-injection care 1
- Screen for contraindications: active infection, uncontrolled diabetes, recent joint replacement (avoid within 3 months of planned arthroplasty) 1
- Warn diabetic patients about transient hyperglycemia occurring days 1-3 post-injection and advise glucose monitoring 1
Optimal Setting
- Clean, quiet, private, well-lit room 1
- Patient positioned on examination table, able to lie flat
- Aseptic equipment prepared
- Resuscitation equipment nearby 1
Injection Technique
Approach Selection
The anterior rotator interval approach is superior to the posterior approach for most shoulder pathology, particularly adhesive capsulitis 3. The rotator interval technique provides:
- Extensive coverage of anterior glenohumeral capsule (100% of cases)
- Reliable infiltration of long head biceps tendon sheath
90% accuracy without imaging guidance 4
The posterior approach should be reserved only when posterior capsule pathology predominates, as it provides inconsistent anterior structure coverage 3.
Ultrasound Guidance
Use ultrasound guidance whenever available - it increases injection accuracy and reduces procedural pain compared to landmark-based techniques 2. However, the modified anterior approach achieves >90% accuracy even without imaging 4.
Corticosteroid Selection and Dosing
Inject 20-40 mg triamcinolone - this is the evidence-based dose range 2, 5. Key dosing principles:
- 20 mg triamcinolone is as effective as 40 mg for shoulder injections 2
- Triamcinolone is the preferred agent (43% of practitioners) 5
- Mix with 2-3 mL of local anesthetic (typically 2% lidocaine) 4
- Total injection volume: 5-10 mL 4
Anatomical Landmarks (Anterior Rotator Interval Approach)
Position the needle:
- Between the coracoid process and humeral head
- Through the rotator interval (space between subscapularis and supraspinatus tendons)
- Directed posteriorly into the glenohumeral joint space 4, 3
Post-Injection Care
Activity Modification
- Avoid overuse for 24 hours following injection 1
- Do NOT immobilize - splinting or prolonged rest adds no benefit and is discouraged 1
- Normal activities may resume after 24 hours
Monitoring
For diabetic patients specifically:
- Monitor blood glucose closely days 1-3 post-injection 1
- Peak hyperglycemia occurs during this window
- No severe events (ketoacidosis, hyperosmolar state) reported in studies 1
Timing Considerations
Disease Stage Matters
Inject early in the disease course for adhesive capsulitis - Stage 1 patients recover ROM within 2-6 weeks versus 7-10 weeks for Stage 2 patients 6. This emphasizes the importance of early recognition and intervention.
Repeat Injections
- Limit to 3-4 injections per year maximum in the same joint 1
- Consider benefits from previous injections before reinjecting
- Shared decision-making should weigh treatment alternatives and individual factors 1
Critical Safety Considerations
Prosthetic Joints
If the shoulder has been replaced:
- Avoid routine injection in prosthetic joints 1
- Infection risk is 0.6% per injection (1 in 625 injections) 1
- Only consider after consultation with orthopedic surgery and strict infection screening 1
Pre-Surgical Timing
Maintain a 3-month window between injection and planned arthroplasty - injections within 3 months of surgery increase prosthetic infection risk from 0.5% to 1.0% 1.